Skip to main content
. 2021 Feb;10(2):790–805. doi: 10.21037/tcr-20-2597

Figure 1.

Figure 1

Rab25 predicts poor prognosis in gastric adenocarcinoma. (A) Comparison of IHC quantification of Rab25 expression from human gastric adenocarcinoma samples and matched normal gastric tissue samples (n=154). ***, P<0.001. (B) IHC staining of Rab25 proteins in human normal gastric tissues versus in human gastric adenocarcinoma samples. (C) Kaplan-Meier survival curves of 154 patients with gastric adenocarcinoma whose tumors had a high or low Rab25 expression. Rab25 high and low groups were separated by the median expression. Significance was determined with log-rank test. P=0.009. Scale bars, 200 µm.